United States · Bill · HR
H.R. 2695 (103rd)
Pharmaceutical Testing Fairness Act
Introduced
21 July 1993
Last action
—
Status
Sponsor introductory remarks on measure. (CR E2186-2187)
Sponsors
—
Subjects
Discovery layer
Source updated
3 June 2026
Summary
Pharmaceutical Testing Fairness Act - Amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to require the inclusion of women and minorities in clinical investigations of new drugs, biological products, and medical devices.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 21 July 1993
Introduced in House (PDF)
Introduced in House · EN · 21 July 1993
Introduced in House
summary · EN · 21 July 1993
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/103rd-congress/house-bill/2695
- Open data entity: https://api.congress.gov/v3/bill/103/hr/2695